Diagnostics Market Research Reports

Diagnostic serves as an intermediary in India’s healthcare industry. The purpose of diagnostic testing is to be performed to detect and monitor conditions. They offer necessary information about the correct treatment and diagnosis of diseases. The diagnostic services are categorized into pathology testing and radiology testing. Diagnostic tests are mostly done in private laboratories equipped with expensive instruments and possess trained and qualified staff who perform the tests.

Diagnostic tests are one of the medical examinations used for diagnosing and recognizing any illness. These tests are mandatory for preventing, managing, and monitoring any disease. The tests are beneficial for improving customer safety, patient treatment, and healthcare costs. As per the reports of the World Health Organization(WHO) regarding Non-communicable illness key facts, by April 2021, chronic diseases will account for about 41 million deaths annually or 71% of all fatalities globally. Due to this, diagnostic tests have signified value in managing chronic illness conditions and identifying, preventing, and diagnosing diseases.

Clinical Diagnostics must open new ways for early intervention and prevention by identifiable early warning indications and individual risk factors. The whole market is expected to grow continuously as the frequency of chronic illnesses risks.

Due to the pandemic of COVID-19, lab testing has increased, resulting in increased demand for suspected COVID-19 cases even faster. As a result, the COVID-19 test count is rising uncontrollably worldwide. According to the Atlantic Monthly Group, the issues rose from 760,441 in September 2020 to 964,792 new tests in October 2020. As a result, due to factors such as an increase in the number of patients and government financing for the increasing number of tests, the demand for COVID-19 test kits increases, and all these factors fuel the overall market growth.

North America is the one that dominates the whole diagnostic tests market due to the growing elderly population. According to the Centers for Condition Control and Prevention(CDC), in the US, around 6 out of 10, people have at least one chronic disease, and 4 out of 10 individuals have two or more. Chronic illnesses like heart disease, diabetes, cancer, and others are the top cause of disability and mortality in the US. As a result, the yearly health expenses amounted to 3.8 trillion USD. So, there is so much need to have adequate medical care in the United States.

In Asia-Pacific, for chronic illnesses, there is an availability of affordable diagnostic tests. Therefore, the nation is anticipated to grow significantly in the forecast period.

In January 2021, in a few nations where CE Mark is accepted, Roche launched its Cobas Pulse System. It is the item that is the networked point-of-care solution from Roche Diagnostics. Most recent releases provide expert blood glucose management.

In September 2021, Immediate Spin Crossmatch(ISXM) was declared by Ortho Clinical Diagnostics. It is the tool used to identify the donor and recipient’s incompatibility in blood transfusions. It will be available on the company’s Ortho Vision Max Analysers and Ortho vision.

Our Life Science category segmentation encompasses:

Medical Devices & Supplies
Healthcare IT

Read More ▾

Latest Reports